LRRK2 pathobiology in Parkinson's disease

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Mutations in leucine-rich repeat kinase 2 (LRRK2) are a primary genetic cause of Parkinson's disease (PD).
• LRRK2 mutations manifest with age-dependent penetrance and clinical phenotypes mirroring sporadic PD.
• Biochemical studies indicate altered kinase and GTPase activity in LRRK2 mutants.

Purpose of the Study:

• To review the biochemical and functional impacts of LRRK2 mutations.
• To elucidate the molecular mechanisms driving LRRK2-associated neurodegeneration.
• To focus on vesicular trafficking and protein synthesis as critical pathways.

Main Methods:

• Review of existing biochemical and functional studies on LRRK2.
• Analysis of cell and animal models of PD linked to LRRK2 mutations.
• Examination of LRRK2's role in vesicular trafficking and protein synthesis.

Main Results:

• LRRK2 mutations increase kinase activity and affect GTPase function, leading to neurotoxicity.
• Disease-linked mutations impact cellular processes including vesicular trafficking, autophagy, and protein synthesis.
• LRRK2 toxicity in models is dependent on alpha-synuclein, which is elevated in patient-derived neurons.

Conclusions:

• Aberrant vesicular trafficking and protein synthesis are identified as leading mechanisms in LRRK2-linked PD.
• Understanding these pathways is crucial for developing targeted therapies for LRRK2 Parkinson's disease.
• Further research is needed to reconcile variable biochemical effects with common neurodegenerative outcomes.